Pomalidomide
- Company Name:Vision Hubei Pharmaceutical Co., Ltd.
- Membership:Free Member
- Member Since:2014. 05.27
- Country/Region:China
- City:Hubei
- Contact:tianyue wu
- Related Keywords:Pomalidomide, CC-4047, 3-amino-thalidomide, Pomalyst
Contact us
Vision Hubei Pharmaceutical Co., Ltd.
[China]
Product name: Pomalidomide
CAS: 19171-19-8
MF:C13H11N3O4
MW:273.24
Description: Pomalidomide (INN, originally CC-4047 or 3-amino-thalidomide, trade name Pomalyst in the US) is a derivative of thalidomide marketed by Celgene. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide was approved in February 2013 by the U.S. Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma.
Other products from this supplier
Related products from premium suppliers on EC21
Browse: Manufacturer Directory Premium Suppliers Site Map
About EC21 Contact Us Terms & Conditions Report Item Online Trading Risks Product Listing Policy
Copyright (c)1997-2026 EC21 Inc. All Rights Reserved. EC21 in KoreanChinese
Business Registry Number: 120-86-03931 | Mall order sales Registration Number: 강남-5838